Histone-modifying enzymes: Their role in the pathogenesis of acute leukemia and their therapeutic potential

Ly P. Vu, Luisa Luciani, Stephen D Nimer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Histone-modifying enzymes have recently been shown to play a central role in the regulation of both normal and malignant hematopoiesis. Post-translational modifications of histones and non-histone proteins underlies a regulatory complexity affecting numerous processes including transcriptional regulation, RNA processing and DNA damage response. Insights into the functions of these enzymes as well as their role in the epigenetic alterations found in leukemia will guide the development of novel therapeutic approaches. This review discusses examples of the proteins that have been implicated in the pathogenesis of leukemia, that may serve as potential therapeutic targets.

Original languageEnglish
Pages (from-to)198-209
Number of pages12
JournalInternational Journal of Hematology
Volume97
Issue number2
DOIs
StatePublished - Feb 1 2013

Fingerprint

Histones
Leukemia
Hematopoiesis
Enzymes
Post Translational Protein Processing
Epigenomics
DNA Damage
Proteins
RNA
Therapeutics

Keywords

  • HATS
  • HDACs
  • Hematopoiesis
  • Histone-modifying enzymes
  • Leukemia
  • PKMTs
  • Post-translational modifications
  • PRMTs

ASJC Scopus subject areas

  • Hematology

Cite this

Histone-modifying enzymes : Their role in the pathogenesis of acute leukemia and their therapeutic potential. / Vu, Ly P.; Luciani, Luisa; Nimer, Stephen D.

In: International Journal of Hematology, Vol. 97, No. 2, 01.02.2013, p. 198-209.

Research output: Contribution to journalArticle

@article{d0412aeaf2f944348ea25f025a54f8c1,
title = "Histone-modifying enzymes: Their role in the pathogenesis of acute leukemia and their therapeutic potential",
abstract = "Histone-modifying enzymes have recently been shown to play a central role in the regulation of both normal and malignant hematopoiesis. Post-translational modifications of histones and non-histone proteins underlies a regulatory complexity affecting numerous processes including transcriptional regulation, RNA processing and DNA damage response. Insights into the functions of these enzymes as well as their role in the epigenetic alterations found in leukemia will guide the development of novel therapeutic approaches. This review discusses examples of the proteins that have been implicated in the pathogenesis of leukemia, that may serve as potential therapeutic targets.",
keywords = "HATS, HDACs, Hematopoiesis, Histone-modifying enzymes, Leukemia, PKMTs, Post-translational modifications, PRMTs",
author = "Vu, {Ly P.} and Luisa Luciani and Nimer, {Stephen D}",
year = "2013",
month = "2",
day = "1",
doi = "10.1007/s12185-012-1247-y",
language = "English",
volume = "97",
pages = "198--209",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Histone-modifying enzymes

T2 - Their role in the pathogenesis of acute leukemia and their therapeutic potential

AU - Vu, Ly P.

AU - Luciani, Luisa

AU - Nimer, Stephen D

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Histone-modifying enzymes have recently been shown to play a central role in the regulation of both normal and malignant hematopoiesis. Post-translational modifications of histones and non-histone proteins underlies a regulatory complexity affecting numerous processes including transcriptional regulation, RNA processing and DNA damage response. Insights into the functions of these enzymes as well as their role in the epigenetic alterations found in leukemia will guide the development of novel therapeutic approaches. This review discusses examples of the proteins that have been implicated in the pathogenesis of leukemia, that may serve as potential therapeutic targets.

AB - Histone-modifying enzymes have recently been shown to play a central role in the regulation of both normal and malignant hematopoiesis. Post-translational modifications of histones and non-histone proteins underlies a regulatory complexity affecting numerous processes including transcriptional regulation, RNA processing and DNA damage response. Insights into the functions of these enzymes as well as their role in the epigenetic alterations found in leukemia will guide the development of novel therapeutic approaches. This review discusses examples of the proteins that have been implicated in the pathogenesis of leukemia, that may serve as potential therapeutic targets.

KW - HATS

KW - HDACs

KW - Hematopoiesis

KW - Histone-modifying enzymes

KW - Leukemia

KW - PKMTs

KW - Post-translational modifications

KW - PRMTs

UR - http://www.scopus.com/inward/record.url?scp=84887603245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887603245&partnerID=8YFLogxK

U2 - 10.1007/s12185-012-1247-y

DO - 10.1007/s12185-012-1247-y

M3 - Article

C2 - 23288492

AN - SCOPUS:84887603245

VL - 97

SP - 198

EP - 209

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 2

ER -